Shockwave Medical (Shockwave Medical) Cash And Cash Equivalents : $281.7 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shockwave Medical Cash And Cash Equivalents?

Shockwave Medical's quarterly cash and cash equivalents declined from Sep. 2023 ($498.11 Mil) to Dec. 2023 ($328.42 Mil) but then stayed the same from Dec. 2023 ($328.42 Mil) to Mar. 2024 ($281.67 Mil).

Shockwave Medical's annual cash and cash equivalents increased from Dec. 2021 ($89.21 Mil) to Dec. 2022 ($156.59 Mil) and increased from Dec. 2022 ($156.59 Mil) to Dec. 2023 ($328.42 Mil).

Shockwave Medical Cash And Cash Equivalents Historical Data

The historical data trend for Shockwave Medical's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical Cash And Cash Equivalents Chart

Shockwave Medical Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

139.05

50.42

89.21

156.59

328.42

Shockwave Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															280.93	141.46	498.11	328.42	281.67

Shockwave Medical Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Shockwave Medical (NAS:SWAV) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Shockwave Medical Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Shockwave Medical (Shockwave Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (NAS:SWAV) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

36M:Germany 36M:Germany

Address

5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054

Website

https://www.shockwavemedical.com

ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Executives

Douglas Evan Godshall	director, officer: President & CEO	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Frank T Watkins	director	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Isaac Zacharias	officer: Chief Commercial Officer	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Dan Puckett	officer: CFO & Secretary	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Trinh Phung	officer: VP, Finance	C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Laura Francis	director	C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Sara Toyloy	director	C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Kevin J. Ballinger	director	C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Antoine Papiernik	director, 10 percent owner	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Sofinnova Capital Vii Fcpr	10 percent owner	C/O SOFINNOVA PARTNERS, 18 RUE DU 4 SEPTEMBRE, 75002 PARIS I0 00000
Cahill Colin	director	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105